CA1085296A - Preparation de cafalexine a action prolongee pour le traitement des infections a bacteries sensibles a la cefalexine - Google Patents

Preparation de cafalexine a action prolongee pour le traitement des infections a bacteries sensibles a la cefalexine

Info

Publication number
CA1085296A
CA1085296A CA276,514A CA276514A CA1085296A CA 1085296 A CA1085296 A CA 1085296A CA 276514 A CA276514 A CA 276514A CA 1085296 A CA1085296 A CA 1085296A
Authority
CA
Canada
Prior art keywords
cefalexin
preparation
coated
normal
granules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA276,514A
Other languages
English (en)
Inventor
Hideyuki Maekawa
Yasushi Takagishi
Hiroshi Kato
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shionogi and Co Ltd
Original Assignee
Shionogi and Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shionogi and Co Ltd filed Critical Shionogi and Co Ltd
Application granted granted Critical
Publication of CA1085296A publication Critical patent/CA1085296A/fr
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cephalosporin Compounds (AREA)
CA276,514A 1976-05-13 1977-04-20 Preparation de cafalexine a action prolongee pour le traitement des infections a bacteries sensibles a la cefalexine Expired CA1085296A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP054925/1976 1976-05-13
JP5492576A JPS52139713A (en) 1976-05-13 1976-05-13 Sustained release cefalexin preparations

Publications (1)

Publication Number Publication Date
CA1085296A true CA1085296A (fr) 1980-09-09

Family

ID=12984185

Family Applications (1)

Application Number Title Priority Date Filing Date
CA276,514A Expired CA1085296A (fr) 1976-05-13 1977-04-20 Preparation de cafalexine a action prolongee pour le traitement des infections a bacteries sensibles a la cefalexine

Country Status (27)

Country Link
JP (1) JPS52139713A (fr)
AR (1) AR224494A1 (fr)
AT (1) AT351159B (fr)
AU (1) AU508793B2 (fr)
BE (1) BE854640A (fr)
CA (1) CA1085296A (fr)
CS (1) CS208196B2 (fr)
DD (1) DD132232A5 (fr)
DE (1) DE2721785A1 (fr)
DK (1) DK208077A (fr)
ES (1) ES458710A1 (fr)
FI (1) FI771491A (fr)
FR (1) FR2350836A1 (fr)
GB (1) GB1543543A (fr)
GR (1) GR68895B (fr)
HU (1) HU184196B (fr)
IE (1) IE45415B1 (fr)
IL (1) IL52075A (fr)
MX (1) MX5976E (fr)
NL (1) NL7704879A (fr)
NZ (1) NZ183927A (fr)
PL (1) PL111183B1 (fr)
PT (1) PT66514B (fr)
RO (1) RO72935A (fr)
SE (1) SE426780B (fr)
SU (1) SU1218919A3 (fr)
ZA (1) ZA772757B (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5545601A (en) * 1978-09-26 1980-03-31 Toyo Jozo Co Ltd Long-acting cephalexin and its preparation
FR2453639A1 (fr) * 1979-04-09 1980-11-07 Sanofi Sa Composition medicamenteuse a liberation programmee immediate-retard a base de naftidrofuryl
JPS5659707A (en) * 1979-10-19 1981-05-23 Toyo Jozo Co Ltd Lasting antibiotic pharmaceutical and its preparation
JPS5826816A (ja) * 1981-08-11 1983-02-17 Teisan Seiyaku Kk 球形顆粒からなる持続性複合顆粒剤
JPS5846019A (ja) * 1981-09-14 1983-03-17 Kanebo Ltd 持続性ニフエジピン製剤
JPS5883613A (ja) * 1981-11-10 1983-05-19 Toa Eiyou Kagaku Kogyo Kk 硝酸イソソルビト−ル製剤
JPS5883106U (ja) * 1981-11-30 1983-06-06 松下電工株式会社 電磁石装置に於けるオイルダツシユポツト
US4525339A (en) * 1982-10-15 1985-06-25 Hoffmann-La Roche Inc. Enteric coated oral dosage form
JPS601128A (ja) * 1983-06-15 1985-01-07 Shionogi & Co Ltd 作用持続型セフアクロル製剤
JPS6144811A (ja) * 1984-08-10 1986-03-04 Ss Pharmaceut Co Ltd 徐放性ジクロフエナクナトリウム製剤
FR2577800B1 (fr) * 1985-02-22 1990-09-07 Grimberg Georges Medicament sous forme galenique gastro-resistante
JPS62226926A (ja) * 1986-03-27 1987-10-05 Teisan Seiyaku Kk 持続性複合顆粒剤
EA200702221A1 (ru) * 2005-04-12 2008-04-28 Элан Фарма Интернэшнл Лимитед Композиции с контролируемым высвобождением для лечения бактериальной инфекции, содержащие цефалоспорин
CN114617855A (zh) * 2020-12-14 2022-06-14 江苏贝佳制药有限公司 头孢氨苄胶囊的制备方法

Also Published As

Publication number Publication date
DK208077A (da) 1977-11-14
RO72935A (fr) 1982-07-06
AU508793B2 (en) 1980-04-03
SU1218919A3 (ru) 1986-03-15
FI771491A (fr) 1977-11-14
AU2507877A (en) 1978-11-16
AR224494A1 (es) 1981-12-15
PL111183B1 (en) 1980-08-30
JPS52139713A (en) 1977-11-21
CS208196B2 (en) 1981-08-31
ATA341877A (de) 1978-12-15
FR2350836A1 (fr) 1977-12-09
PL198058A1 (pl) 1979-03-26
ZA772757B (en) 1978-04-26
NL7704879A (nl) 1977-11-15
GR68895B (fr) 1982-03-15
HU184196B (en) 1984-07-30
ES458710A1 (es) 1978-03-01
SE7705502L (sv) 1977-11-14
IL52075A (en) 1980-06-30
GB1543543A (en) 1979-04-04
PT66514A (en) 1977-06-01
IL52075A0 (en) 1977-07-31
IE45415L (en) 1977-11-13
AT351159B (de) 1979-07-10
PT66514B (en) 1978-10-16
DD132232A5 (de) 1978-09-13
MX5976E (es) 1984-09-12
FR2350836B1 (fr) 1981-02-06
DE2721785A1 (de) 1977-11-24
SE426780B (sv) 1983-02-14
NZ183927A (en) 1980-02-21
BE854640A (fr) 1977-09-01
IE45415B1 (en) 1982-08-25
JPS5547611B2 (fr) 1980-12-01
DE2721785C2 (fr) 1989-03-16

Similar Documents

Publication Publication Date Title
US4250166A (en) Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
EP0129382B1 (fr) Formulation de céfaclor à action prolongée et sa préparation
CA1085296A (fr) Preparation de cafalexine a action prolongee pour le traitement des infections a bacteries sensibles a la cefalexine
RU2095054C1 (ru) Твердая лекарственная форма для орального введения
EP0466566B1 (fr) Médicament sous forme solide enrobé pouvant être libéré dans l'intestin gros
EP0572486B1 (fr) Formes pharmaceutiques orales a liberation prolongee servant au traitement de troubles intestinaux
US4980173A (en) Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration
EP0565210B1 (fr) Véhicules pour l'administration orale de substances pharmaceutiques sensibles aux acides
CA2041400C (fr) Preparation d'un medicament
US4772473A (en) Nitrofurantoin dosage form
US4806361A (en) Medicaments in sustained release unit dose form
US20220062188A1 (en) All-in-one fixed-dose combination for treating helicobacter pylori infection
JP2002508312A (ja) 多重治療法における有効成分の投与のための二重カプセル
CZ455990A3 (en) Pharmaceutical application system and process for producing thereof
CN107148473A (zh) β‑内酰胺酶制剂及其用途
EP0222914A1 (fr) Preparation antibiotique granulaire composite stabilisee
US8357394B2 (en) Compositions and methods for improved efficacy of penicillin-type antibiotics
Jemsek et al. Haemophilus parainfluenzae endocarditis: two cases and review of the literature in the past decade
US20060159757A1 (en) Pharmaceutical composition for controlled release of beta-lactam antibiotics in combination with beta-lactamase inhibitors
CN102844024A (zh) 基于4-硫脲基-亚氨基甲基吡啶鎓高氯酸盐的结核病药物:制备和治疗方法
WO1990004395A1 (fr) Composition nouvelle et procede anti-miction

Legal Events

Date Code Title Description
MKEX Expiry